Anokion SA;Ecole Polytechnique Federale de Lausanne (EPFL)
发明人:
Jeffrey A. Hubbell,Stephane Kontos,Kristen Marie Lorentz,David Scott Wilson,Shuning Gai
申请号：
US16723774
公开号：
US20200121762A1
申请日:
2019.12.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.
